Evidence map›Paper›PMID 31630278›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2019

Metabolomic identification of novel diagnostic biomarkers in ectopic pregnancy.

Onur Turkoglu, Ayse Citil, Ceren Katar, Ismail Mert, Praveen Kumar, Ali Yilmaz, Dilek S Uygur, Salim Erkaya, Stewart F Graham, Ray O Bahado-Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A comparison of high-throughput plasma NMR protocols for comparative untargeted metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Onur TurkogluDepartment of Obstetrics and Gynecology, Beaumont Health System, Royal Oak, MI, USA. onur.turkoglu@beaumont.org.ORCID 0000-0003-4286-7481
Ayse CitilDepartment of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
Ceren KatarDepartment of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
Ismail MertDivision of Gynecological Oncology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Praveen KumarDepartment of Obstetrics and Gynecology, Beaumont Health System, Royal Oak, MI, USA.
Ali YilmazDepartment of Obstetrics and Gynecology, Beaumont Health System, Royal Oak, MI, USA.
Dilek S UygurDepartment of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
Salim ErkayaDepartment of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
Stewart F GrahamDepartment of Obstetrics and Gynecology, Beaumont Health System, Royal Oak, MI, USA.
Ray O Bahado-SinghDepartment of Obstetrics and Gynecology, Beaumont Health System, Royal Oak, MI, USA.
Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi · TROakland University · USBeaumont Health · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEctopic pregnancy (EP) is a potentially life-threatening condition and early diagnosis still remains a challenge, causing a delay in management leading to tubal rupture.

objectivesTo identify putative plasma biomarkers for the detection of tubal EP and elucidate altered biochemical pathways in EP compared to intrauterine pregnancies.

methodsThis case-control study included prospective recruitment of 39 tubal EP cases and 89 early intrauterine pregnancy controls. Plasma samples were biochemically profiled using proton nuclear magnetic resonance spectroscopy (

resultsIn total 13 of 43 (30.3%) metabolite concentrations were significantly altered in EP plasma (p < 0.05). Metabolomic profiling yielded significant separation between EP and controls (p < 0.05). Independent validation of a two-metabolite model consisting of lactate and acetate, achieved an AUC (95% CI) = 0.935 (0.843-1.000) with a sensitivity of 92.3% and specificity of 96.6%. The second metabolite model (D-glucose, pyruvate, acetoacetate) performed well with an AUC (95% CI) = 0.822 (0.657-0.988) and a sensitivity of 84.6% and specificity of 86.2%.

conclusionWe report novel metabolomic biomarkers with a high accuracy for the detection of EP. Accurate biomarkers could potentially result in improved early diagnosis of tubal EP cases.

Indexed as

MetabolomicsAdultBiomarkersCase-Control StudiesFemaleHumansPregnancyPregnancy, EctopicProspective StudiesProton Magnetic Resonance SpectroscopyTurkeyBiomarkersBiomarkerEctopic pregnancyMetaboliteMetabolomicsNuclear magnetic resonance spectroscopy

Identifiers

PMID31630278
OpenAlexW2980894737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.